If you liked this article you might like

Cellectis Gains FDA Nod to Test New Gene-Edited Cancer Treatment
Cellectis Gets FDA Nod to Test New Gene-Edited Cancer Treatment
13 Companies to Watch From MIT's Smart 50 List, Including 4 Buys
Trade-Ideas: Cellectis (CLLS) Is Today's Weak On High Relative Volume Stock